a clinical-stage company, which engages in developing treatments for rare and specialty diseases with significant unmet needs.
Industry Biotechnology
A.I.dvisor tells us that TARA and CDIO have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TARA and CDIO's prices will move in lockstep.
Ticker / NAME | Correlation To TARA | 1D Price Change % | ||
---|---|---|---|---|
TARA | 100% | +1.63% | ||
CDIO - TARA | 31% Poorly correlated | -24.11% | ||
DNA - TARA | 26% Poorly correlated | +1.91% | ||
VERA - TARA | 26% Poorly correlated | -0.11% | ||
ZLAB - TARA | 24% Poorly correlated | +3.02% | ||
VIR - TARA | 24% Poorly correlated | -2.78% | ||
More |